RxDoctor Payments Data

Aaron Vandenbos, MD

Orthopaedic Surgery · Moscow, IDNPI 1740571066

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (55.4%), education and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Smith+Nephew at 45.9% of the total. Reporting peaked in 2022 at $7,885 and has fallen 85.7% since, to $1,128 in 2025.

$11,969in general payments, 2019–2025

Across 41 payments — averaging $291.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$5K
  • Arthrex$3K
  • Summit Surgical Corp.$2K
  • Johnson & Johnson$1K
  • Sawtooth Surgical Solutions Inc$105
  • Medical Device Business Services, Inc.$32
  • plus $53 from 2 others

What the payments were for

  • Travel & lodging$6,63755%
  • Food & beverage$1,73314%
  • Education$3,60030%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew20$5,489
Arthrex9$3,328
Summit Surgical Corp.3$1,735
Johnson & Johnson3$1,228
Sawtooth Surgical Solutions Inc2$105
Medical Device Business Services, Inc.2$32
Vericel Corporation1$27
Avanos Medical1$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,969 in reported general payments places this provider in the 70th percentile of 139 orthopaedic surgery providers in Idaho.

See all orthopaedic surgery providers in Idaho

Medicare billing

Part B allowed, 2024
$90,900
Medicare patients
193
Services billed
1,484

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl38$127
Ibuprofen24$100
Gabapentin21$46

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Moscow

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →